Literature DB >> 10092890

Prospective randomised trial of distal arteriovenous fistula as an adjunct to femoro-infrapopliteal PTFE bypass.

A Hamsho1, D Nott, P L Harris.   

Abstract

OBJECTIVES: To compare graft patency and limb salvage rate following femoro-infrapopliteal bypass using ePTFE grafts with and without the addition of adjuvant arterio-venous fistula.
DESIGN: A prospectively randomised controlled trial. MATERIALS: Patients referred to two teaching hospital vascular surgery units in the U.K. for the treatment of critical limb ischaemia.
METHODS: Eighty-seven patients (M:F; 2.3:1) undergoing 89 femoro-intrapopliteal bypass operations with ePTFE grafts for critical limb ischaemia were randomly allocated to have AVF included in the operative procedure (n = 48) or to a control group without AVF (n = 41). An interposition vein-cuff was incorporated at the distal anastomosis in all patients.
RESULTS: The cumulative rates of primary patency and limb salvage at 1-year after operation for patients with AVF were 55.2% and 54.1% compared to 53.4% and 43.2%, respectively, for the control group. The differences between the AVF and control groups did not reach statistical significance, in terms of either graft patency or limb salvage, at any stage after operation (Log-Rank test).
CONCLUSIONS: AVF confers no additional significant clinical advantage over interposition vein cuff in patients having femoro-infrapopliteal bypass with ePTFE grants for critical limb ischaemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092890     DOI: 10.1053/ejvs.1998.0671

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  3 in total

Review 1.  Bypass surgery for chronic lower limb ischaemia.

Authors:  George A Antoniou; George S Georgiadis; Stavros A Antoniou; Ragai R Makar; Jonathan D Smout; Francesco Torella
Journal:  Cochrane Database Syst Rev       Date:  2017-04-03

2.  An aggressive policy of bilateral saphenous vein harvest for infragenicular revascularisation in the era of multidrug resistant bacteria.

Authors:  G J Murphy; D Kipgen; M J S Dennis; R D Sayers
Journal:  Postgrad Med J       Date:  2002-06       Impact factor: 2.401

3.  Arteriovenous fistula as adjuvant treatment in arterial revascularization of an at-risk limb.

Authors:  Júlio César Gomes Giusti; Sabrina Payne Tartarotti; Fabio Henrique Rossi; João Paulo Neves Beraldo; Francisco Cardoso Brochado
Journal:  J Vasc Bras       Date:  2021-09-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.